TampaTradr, actually it is not a dream and the statement, with which many in the field do agree, was based on patient perception.
The market today for such test is WAY bigger then the cash it generates. The reason is the CUMBERSOME technique, or for some patients the religious, cultural or other reasons not to take such test. I think intestinal cancer scanning is the best example for the non-hurtful tests and tissue biopsy test are the best example of hurtful test. PAB smears are probably the widest spread and still not accepted in all countries due to religion or cultural obstacles.
The early cancer detection test by simple liquid biopsy on a blood sample, which PPHM's test is, with HIGH ACCURACY, which PPHM test is, CHEAP and FAST, which PPHM test is, would change the complete field and open a market that is there but could NOT be tapped in till now.
People have blood samples taken for all reasons. It is easy, fast and can be done when the Doctor visits you at home, or by a mobile nurse, by hemo-teams in hospitals and even Humanitarian teams in Africa. So the threshold would be GONE, the other obstacles would be GONE (except some small religions which forbid blood-taking).
You'dd have an early cancer detection test with your annual check-up so to speak. Every military would have it and children would have it as part of the schools mandatory yearly medical exam programs that test already plenty of stuff based on blood tests.
So the market is enormous because it replaces plenty of different scanning and detection techniques that are already their now, have mostly lots of false positives or false negatives, are expensive, time consuming, generate patient stress by waiting for the results, etc.
That is why the statement included: EARLY CANCER DETECTION - TYPE OF CANCER INDICATION - RELIABLE - LIQUID (BLOOD BASED).
And we PPHM shareholders must now create AWARENESS of that instead of letting us manoeuvre into the believe that it is all worthless.
AIMO
Market Data 
Markets 
AI
